DZ Bank
BIO icon

DZ Bank’s Bio-Rad Laboratories Class A BIO Stock Holding History

DZ Bank’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$511K Buy
+1,834
New +$528K ﹤0.01% 805
2024
Q2 		– Sell
-1,936
Closed -$670K – 1032
2024
Q1 		$670K Hold
1,936
– – ﹤0.01% 744
2023
Q4 		$625K Hold
1,936
– – ﹤0.01% 720
2023
Q3 		$694K Hold
1,936
– – ﹤0.01% 687
2023
Q2 		$734K Buy
+1,936
New +$788K ﹤0.01% 710
2022
Q3 		– Sell
-5,971
Closed -$2.96M – 1018
2022
Q2 		$2.96M Sell
5,971
-11,344
-66% -$5.91M 0.01% 538
2022
Q1 		$9.75M Buy
17,315
+14,489
+513% +$8.73M 0.01% 368
2021
Q4 		$2.14M Buy
+2,826
New +$2.11M ﹤0.01% 631

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return